Handa Pharmaceuticals, Inc.

TPEX:6620 Stock Report

Market Cap: NT$8.2b

Handa Pharmaceuticals Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Toshiyo Chen

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownership0.3%
Management average tenure8.3yrs
Board average tenureno data

Recent management updates

Recent updates

Handa Pharmaceuticals'(GTSM:6620) Share Price Is Down 26% Over The Past Three Years.

Feb 24
Handa Pharmaceuticals'(GTSM:6620) Share Price Is Down 26% Over The Past Three Years.

We Think Handa Pharmaceuticals (GTSM:6620) Can Afford To Drive Business Growth

Dec 29
We Think Handa Pharmaceuticals (GTSM:6620) Can Afford To Drive Business Growth

CEO

Toshiyo Chen

no data

Tenure

Mr. Toshiyo Chen serves as General Manager and Director of Handa Pharmaceuticals, Inc. Mr. Chen has corporate management experience, specializes in the management, corporate governance, negotiation, market...

Leadership Team

NamePositionTenureCompensationOwnership
Fang-Yu Liu
Founder & Chairmanno datano data0.17%
NT$ 14.4m
Toshiyo Chen
GM & Directorno datano data0.25%
NT$ 20.6m
Chi-Yu Yang
Vice President of Financeno datano datano data
Guo-Chun Song
Chief Technology Officerno datano data0.17%
NT$ 13.8m
Zhong-Yi Duan
Vice President of Regulation8.2yrsno data0.096%
NT$ 7.9m
Mei-Fang Chang
Senior VP of Quality Affairs & Director8.3yrsno data0.34%
NT$ 27.7m
Stephen Cary
Senior Vice President of Business Development8.3yrsno data0.035%
NT$ 2.9m

8.3yrs

Average Tenure

Experienced Management: 6620's management team is seasoned and experienced (8.3 years average tenure).